Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1974 Jun;27(6):473–479. doi: 10.1136/jcp.27.6.473

The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays

Ayesha Molla 1,1, Maria Benedetta Donati 1,2, J Vermylen 1
PMCID: PMC478158  PMID: 4137968

Abstract

Agglutination inhibition immunoassays using antifibrinogen antiserum measure an antigenic determinant of fibrinogen which is located on the fragment D parts of this molecule. This antigenic determinant of fragment D, in contrast to others, does not form an immune precipitate with antifibrinogen antiserum. Upon very extensive hydrolysis by plasmin, this antigenic determinant has a reduced affinity for its antibody.

Full text

PDF
473

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allington M. J. Detection of fibrin(ogen) degradation products by a latex clumping method. Scand J Haematol Suppl. 1971;13:115–119. doi: 10.1111/j.1600-0609.1971.tb01996.x. [DOI] [PubMed] [Google Scholar]
  2. Donati M. B., Molla A., Vermylen J. The Tanned Red Cell Hemagglutination Inhibition Immunoassay and purified fibrinogen degradation products. Scand J Haematol Suppl. 1971;13:91–99. doi: 10.1111/j.1600-0609.1971.tb01992.x. [DOI] [PubMed] [Google Scholar]
  3. Donati M. B., Vermylen J., Verstraete M. The staphylococcal clumping test for detection of fibrinogen-like material. Scand J Haematol Suppl. 1971;13:137–143. doi: 10.1111/j.1600-0609.1971.tb01999.x. [DOI] [PubMed] [Google Scholar]
  4. Dudek-Wojciechowska G. A., Kloczewiak M., Latallo Z. S., Kopeć M. Characterisation of large fragments rich in disulphide bridges from CNBr-treated products of exhaustive proteolysis of fibrinogen by plasmin. Biochim Biophys Acta. 1973 Feb 21;295(2):536–542. doi: 10.1016/0005-2795(73)90050-0. [DOI] [PubMed] [Google Scholar]
  5. Feddersen C., Gormsen J. Plasmin digestion of stabilized and non-stabilized fibrin illustrated by immunoelectrophoresis and haemagglutination inhibition immuno assays. Scand J Haematol. 1971;8(6):461–469. doi: 10.1111/j.1600-0609.1971.tb00899.x. [DOI] [PubMed] [Google Scholar]
  6. Latallo Z. S., Dudek G. A., Kloczewiak M. A possible relation between the location of D and E fragments and of the N-terminal disulphide knots in fibrinogen molecule. Scand J Haematol Suppl. 1971;13:37–41. doi: 10.1111/j.1600-0609.1971.tb01982.x. [DOI] [PubMed] [Google Scholar]
  7. Marder V. J. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen. Scand J Haematol Suppl. 1971;13:21–36. doi: 10.1111/j.1600-0609.1971.tb01981.x. [DOI] [PubMed] [Google Scholar]
  8. Marder V. J., James H. L., Sherry S. The purification of fibrinogen degradation products by pevikon block electrophoresis. Thromb Diath Haemorrh. 1969 Nov 15;22(2):234–239. [PubMed] [Google Scholar]
  9. Marder V. J., Shulman N. R., Carroll W. R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem. 1969 Apr 25;244(8):2111–2119. [PubMed] [Google Scholar]
  10. Marder V. J., Shulman N. R., Carroll W. R. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Trans Assoc Am Physicians. 1967;80:156–167. [PubMed] [Google Scholar]
  11. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  12. Merskey C., Lalezari P., Johnson A. J. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med. 1969 Jul;131(3):871–875. doi: 10.3181/00379727-131-33998. [DOI] [PubMed] [Google Scholar]
  13. Merskey C., Lalezari P., Johnson A. J. Tanned Red Cell Hemagglutination Inhibition Immunoassay for fibrinogen-fibrin-related antigen ("fibrinolytic degradation products") in human serum. Scand J Haematol Suppl. 1971;13:83–85. [PubMed] [Google Scholar]
  14. Molla A., Donati M. B., Dotremont G., Vermylen J. Comparison of the Tanned Red Cell Hemagglutination Inhibition Immuno-assay and radial immunodiffusion for the quantitation of fibrinogen-related antigen in urine concentrates. Scand J Haematol Suppl. 1971;13:225–228. doi: 10.1111/j.1600-0609.1971.tb02012.x. [DOI] [PubMed] [Google Scholar]
  15. NUSSENZWEIG V., SELIGMANN M., PELMONT J., GRABAR P. [The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties]. Ann Inst Pasteur (Paris) 1961 Mar;100:377–389. [PubMed] [Google Scholar]
  16. NUSSENZWEIG V., SELIGMANN M. [Analysis, by immuno-chemical methods, of the degradation by plasmin of human fibrinogen and fibrin, at different stages]. Nouv Rev Fr Hematol. 1960 Nov-Dec;15:451–466. [PubMed] [Google Scholar]
  17. Pizzo S. V., Schwartz M. L., Hill R. L., McKee P. A. The effect of plasmin on the subunit structure of human fibrinogen. J Biol Chem. 1972 Feb 10;247(3):636–645. [PubMed] [Google Scholar]
  18. Plow E., Edgington T. S. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J Clin Invest. 1973 Feb;52(2):273–282. doi: 10.1172/JCI107183. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES